AMA Capital has expanded its team following appointment of nine sector specialists, including ex-Olympian Adrian Moorhouse, just one month after the addition of three Non-Executive Partners.
Welsh, Carson, Anderson & Stowe (WCAS), a private equity firm focused on healthcare and technology, has appointed Brian Kane as a Senior Advisor to its Healthcare Group.
Tungsten Automation Corporation, a provider of AI-powered document and workflow automation solutions backed by Clearlake Capital Group, and TA Associates (TA), has promoted Peter Hantman to Chief Executive Officer.
Brookfield Asset Management, Stonepeak, and Air Liquide have been shortlisted by Macquarie Asset Management for the final bidding round in the sale of South Korean industrial gas producer DIG Airgas, according to a report by Reuters citing unnamed sources familiar with the matter.
Cerberus Capital Management and consumer sector veteran Dean Metropoulos mounted a serious, though ultimately unsuccessful, bid for cereal maker WK Kellogg, according to a report by Reuters citing unnamed sources familiar with the matter.
NexPhase Capital, a thematically driven and operationally focused private equity firm, has sold non-alcoholic cocktail mix brand Zing Zang to Mizkan America. Terms of the transaction were not disclosed.
Consumer-focused private equity firm Main Post has made a minority growth investment in Smoothie King, a global purpose-driven smoothie brand, positioning the brand for accelerated growth, innovation, and market leadership.
Investcorp has completed the sale of a majority stake in leading Italian cybersecurity provider HWG Sababa by Investcorp Technology Partners Fund V and certain other investors, to an oversubscribed €240m single-asset continuation fund managed by Investcorp.
Private credit managers are increasing leverage ratios and offering more flexible structures to win mandates from private equity sponsors, as competition with the resurgent broadly syndicated loan (BSL) market heats up, according to a report by Bloomberg.
New York-based SK Capital Partners, which focuses on the specialty materials, ingredients, and life sciences sectors, has entered into exclusive negotiations with LISI Group to acquire LISI Group’s Medical division, through its affiliate.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
